Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer

Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer

ASCO 2026: Lung cancer roundup

ASCO 2026: Highlights and analysis

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer

Short-term fasting linked to improved chemo response in advanced ovarian cancer

ASCO 2026: Latest in prostate cancer

Gene expression test guided therapy in ER+/HER2- early breast cancer allows safe chemotherapy omission

Tarlatamab in SCLC shows consistent effect and low immune toxicity across age groups

Darovasertib plus crizotinib improves outcomes in HLA-A2–negative metastatic uveal melanoma

Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

ASCO 2026: Latest updates in mRCC